Navigation Links
Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
Date:6/22/2013

ents and 0.0 percent of placebo patients. In addition, investigator-defined hypoglycemia occurred in 0.5 percent of linagliptin patients and 0.0 percent of placebo patients in the monotherapy study, and in 1.0 percent of patients in both groups of the add-on study.3, 4

About the Studies
The first study was a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of linagliptin monotherapy for 24 weeks in Asian patients with inadequately controlled type 2 diabetes mellitus. The study included a total of 300 patients with T2D from China (n=261), Malaysia (n=22) and the Philippines (n=17). Patients who were treatment naïve or who had been treated with one antihyperglycemic drug were randomized to either linagliptin 5 mg daily or placebo following a 4-week washout period of prior drugs. The primary endpoint was change from baseline in mean HbA1c after 24 weeks.3 Mean HbA1c levels at baseline were 7.95 percent for patients in the linagliptin group and 8.09 percent for patients in the placebo group.

The second study, also a randomized, double-blind, placebo-controlled trial, evaluated the efficacy and safety of linagliptin as add-on therapy to metformin in Asian patients with inadequately controlled type 2 diabetes mellitus. The study included a total of 306 patients with T2D from China (n=265), Malaysia (n=17) and the Philippines (n=24). Antihyperglycemic drugs other than metformin were washed out for 4 weeks prior to randomization to either linagliptin 5mg daily or placebo added to metformin. The primary endpoint of the study was change from baseline in mean HbA1c after 24 weeks.4 Mean HbA1c levels at baseline were 7.99 percent for patients in the linagliptin group and 8.00 percent for pa
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 BRIC Biopsy Devices ... GlobalData,s new report, "BRIC Biopsy Devices Market Outlook ... Biopsy Devices market. The report provides value, in millions ... (in US dollars) within market segments - Biopsy Guns ... Fine Aspiration Needles (Disposable and Reusable Fine Aspiration Needles) ...
(Date:9/17/2014)... 17, 2014 The ambulance equipment ... decade due to the recession, an unstable ... advancements. This BCC Research report analyzes present ... the ambulance and emergency medical services equipment ... hemorrhage control devices, equipment used for burn ...
(Date:9/17/2014)... 2014 /PRNewswire-iReach/ -- ChemImage announced today the ... in the development of imaging technology used ... and diseased tissue that minimizes the learning ... lowers surgical costs and potentially enhances patient ... The clinical and scientific teams at ...
Breaking Medicine Technology:BRIC Biopsy Devices Market Outlook to 2020 2BRIC Biopsy Devices Market Outlook to 2020 3Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2
... , , DURHAM, N.C., Jan. 8 Oxygen ... common stock has been approved for listing on the NASDAQ ... to the NASDAQ is a very important milestone for our ... listed on the NASDAQ provides us with greater visibility for ...
... , , , FARMINGDALE, N.Y., Jan. ... of minimally invasive ultrasonic medical device technology, which in Europe ... other acute health conditions, has entered into a new, three ... in Riyadh, Kingdom of Saudi Arabia, for the distribution of ...
Cached Medicine Technology:Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing 2Misonix Announces New Distribution Agreement for Kingdom of Saudi Arabia 2Misonix Announces New Distribution Agreement for Kingdom of Saudi Arabia 3
(Date:9/17/2014)... Boston Children’s Museum and From ... concert series, introducing young Museum visitors to musicians ... premier national platform celebrating the stories, talents, and ... young musicians featured will also be showcased on ... is fortunate to partner with the wonderful musicians ...
(Date:9/17/2014)... 17, 2014 A petition to ban ... laparoscopic hysterectomies and other gynecological surgeries has gathered nearly ... posted on Change.org, at least 84,908 supporters had signed ... to a recent report from ABC News, the Change.org ... Hooman Noorchashm, after his wife, Dr. Amy Reed, was ...
(Date:9/17/2014)... (HealthDay News) -- Present-day Europeans are the descendants ... according to a new study. Previous ... and early European farmers. But, a new genetic ... also the descendants of Ancient North Eurasians. Nearly ... third ancestral group, researchers from Harvard Medical School ...
(Date:9/17/2014)... is not properly designed to meet the needs of ... their families, and major changes to the system are ... Medicine. The 21-member committee that wrote the report ... medical care and social services and that is high-quality, ... "advance care planning" for end-of-life by individuals, for improved ...
(Date:9/17/2014)... 2014 Mercy “topped out” the world’s ... final beam into place. Sister of Mercy Claudia Ward ... (Photos and video of the event, including footage from ... http://bit.ly/MercyVirtual .) , “The topping out means we ... to thousands of patients regardless of the hour or ...
Breaking Medicine News(10 mins):Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 3Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 4Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 3Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 2Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 3Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 4Health News:US health system not properly designed to meet needs of patients nearing end of life, says IOM 5Health News:Mercy Tops Out World's First Virtual Care Center 2
... Flu Granted Conditional License by USDA , ... Health, the global leader in veterinary biologicals, today ... canine influenza virus (CIV), which was granted a ... Department of Agriculture (USDA) on May ...
... ,Kidney Walk, At Soldier Field , , MOUNTAIN VIEW, ... first and leading providers of kidney dialysis services and a ... the National Kidney Foundation (NKF) of Illinois, Kidney Walk in ... will be held Sunday, June 28, 2009 at Soldier Field ...
... , , , Teva Pharmaceuticals Hosting Second ... Campaign , , CHICAGO, June 23 According ... of three people in Illinois under the age of 65 ... awareness to the healthcare issues facing everyday Americans, on June ...
... Philadelphia Opens Free-Standing Inpatient Unit , ... These are the adjectives Hospice of Philadelphia considered when it developed ... patient in their own home is ideal, but is not always ... hospital. The new hospice unit provides patients and their families ...
... and NEW YORK, June 23 The ... the American University of Beirut Medical Center ... The Magnet program recognizes nursing excellence "in the ... services in an environment that supports professional nursing practice, ...
... a new breast biopsy technique that could lead to ... according to a study performed at Roberts Research Institute, ... Centre, London, ON, Canada. The new technique uses a ... and has a braking system to allow for accurate ...
Cached Medicine News:Health News:New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus 2Health News:New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus 3Health News:New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus 4Health News:Satellite Healthcare Supports Kidney Wellness in Chicago 2Health News:Businesses, Community Leaders Invited to Come Together to Examine the Rising Cost of Healthcare 2Health News:Unique Facility Designed for the Comfort of Hospice Patients and Their Families 2Health News:Unique Facility Designed for the Comfort of Hospice Patients and Their Families 3Health News:AUB Medical Center Designated First 'Magnet' Facility in the Middle East 2Health News:AUB Medical Center Designated First 'Magnet' Facility in the Middle East 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: